1. P843: METABOLOMIC CHARACTERIZATION OF HUMAN MULTIPLE MYELOMA CELL LINE TO STUDY TUMOR RESISTANCE TO DIFFERENT CLASSES OF THERAPEUTIC AGENTS. (23rd June 2022) Authors: Steer, A.; Chemlal, D.; Varlet, E.; Machura, A.; Kassambara, A.; Alaterre, E.; Requirand, G.; Robert, N.; Hirtz, C.; De Boussac, H.; Bruyer, A.; Moreaux, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P844: CHARACTERIZATION OF MULTIPLE MYELOMA CELL LINES WITH ACQUIRED-RESISTANCE TO PROTEASOME INHIBITORS HIGHLIGHTS A LINK BETWEEN RESISTANCE AND METABOLIC DEREGULATION. (23rd June 2022) Authors: De Boussac, H.; Machura, A.; Steer, A.; Kassambara, A.; Gely, M.; Chemlal, D.; Gourzones, C.; Requirand, G.; Robert, N.; Vincent, L.; Herbaux, C.; Bruyer, A.; Moreaux, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 738 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗